Skip to content

The effects of providing asymmetrical guidance during Lokomat guided gait on muscle activity in persons with post-stroke hemiparesis

The effects of providing asymmetrical guidance during Lokomat guided gait on muscle activity in persons with post-stroke hemiparesis - The effect of asymmetrical guidance in the Lokomat

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44481
Enrollment
10
Registered
2017-10-31
Start date
2017-12-15
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accident (CVA)

Interventions

A total of 20 (2 for each muscle
10 per leg) self-adhesive electrodes will be placed on the skin of the participants.

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. A first unilateral stroke (infarction or haemorrhage). 2. At least three months post onset. 3. A unilateral paresis of the leg. 4. A Functional Ambulation Categories Score (FAC) of 2 (*Patient requires manual contact of one person during ambulation on level surfaces*) to 5 (*Ambulation is independent on unlevel and level surfaces, stairs, and inclines*). 5. Patient should be 45 - 70 years old at the time of inclusion 6. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Severely impaired cognitive functions (Mini Mental State Exam score *25). 2. Severe speech, language or communication disorders (it will be left to clinical judgment whether the patient is able to understand instructions and to provide informed consent; in case of doubt the Aachen Aphasia Test will be administered). 3. Insufficient working knowledge of the Dutch language to understand instructions and provide informed consent (clinical judgment). 4. Severe visual problems (clinical judgment). 5. Severe neglect (clinical judgment through observation. In case of doubt, the Star Cancelation Test can be administered). 6. Polyneuropathy (clinical judgement) 7. Co-morbidity that can affect the results of the study (e.g. pre-existent problems in leg function or a progressive neurological disorder). 8. Participation in other scientific studies.

Design outcomes

Primary

MeasureTime frame
The amplitude of muscle activity in µvolts.

Secondary

MeasureTime frame
D.N.A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)